Grand Rounds: Risk Modeling for Targeting Therapies to Those who can Benefit

Name: Grand Rounds: Risk Modeling for Targeting Therapies to Those who can Benefit
Uploaded: 2014-01-31T00:00:00+00:00
Description: David Kent, M.D., M.S., presents Risk Modeling for Targeting Therapies to Those who can Benefit.

David Kent, M.D., M.S., presents Risk Modeling for Targeting Therapies to Those who can Benefit.

Published

January 31, 2014

Created by

Related Videos

Saving lives with Gus: Ice fishing safety

Cornelius A. Thiels, D.O., M.B.A., and Martin D. Zielinski, M.D., Mayo Clinic physicians, share research findings on injuries experienced while ice fishing.

Center volume and hereditary hemorrhagic telangiectasia

Vivek N. Iyer, M.D., with Pulmonary and Critical Care Medicine at Mayo Clinic in Rochester, Minnesota, discusses a study of patients with the rare disease hereditary hemorrhagic telangiectasia.

Mayo Clinic researchers reduce inflammation in human cells, a major cause of frailty

Mayo Clinic researchers have discovered that targeting select pathways with JAK inhibitors reduced inflammation in human cells in culture dishes and decreased inflammation and frailty in aged mice.

Grand Rounds: Learning Healthcare Systems and the Veterans Affairs Clinical Assessment, Reporting and Tracking Program

Tom Maddox, M.D., presents Learning Healthcare Systems and the Veterans Affairs Clinical Assessment, Reporting and Tracking Program.

Mayo Clinic and collaborators find new class of drugs that reduces aging in mice

James L. Kirkland, M.D., Ph.D., discusses a study finding a new class of drugs, identified and validated by Mayo Clinic researchers and their collaborators, clearly reduces health problems in mice by limiting the effect of senescent cells.

The Pharmacokinetics Core: A resource for translational science innovation and drug development

Joel M. Reid, Ph.D, presents The Pharmacokinetics Core: A Resource for Translational Science Innovation and Drug Development.

Grand Rounds: The Analytical Odyssey of the Diagnostic Odyssey

Eric W. Klee, Ph.D., and Patrick R. Blackburn, Ph.D., present The Analytical Odyssey of the Diagnostic Odyssey.

Grand Rounds: Ethics, Health Informatics and Translational Science

Kenneth W. Goodman, Ph.D., presents Ethics, Health Informatics and Translational Science.

Grand Rounds — Chemistry to Clinic: The Nanosyn Approach to Bridging the Gaps in Translational Research

Nikolai Sepetov, Ph.D., CEO, and chief scientific officer of Nanosyn Inc., presents Chemistry to Clinic: The Nanosyn Approach to Bridging the Gaps in Translational Research.

Medical Professional Video Center

Search Video Center